Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q1

2796.TEDINET S100PCXQ
Period2022-06-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥12.9bn2022-06-01 → 2022-08-31Cons.Net sales
Revenue¥51.6bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥13.1bn2021-06-01 → 2021-08-31Cons.Net sales
Operating income¥348m2022-06-01 → 2022-08-31Cons.Operating income
Operating income¥317m2021-06-01 → 2021-08-31Cons.Operating income
Ordinary income¥341m2022-06-01 → 2022-08-31Cons.Ordinary income
Ordinary income¥1.5bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥335m2021-06-01 → 2021-08-31Cons.Ordinary income
Profit before tax¥318m2022-06-01 → 2022-08-31Cons.Income before income taxes
Profit before tax¥293m2021-06-01 → 2021-08-31Cons.Income before income taxes
Net income (owners)¥111m2022-06-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥447m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥63m2021-06-01 → 2021-08-31Cons.Profit loss attributable to owners of parent
Net income¥114m2022-06-01 → 2022-08-31Cons.Profit loss
Net income¥62m2021-06-01 → 2021-08-31Cons.Profit loss
Total assets¥23.2bnat 2022-08-31Cons.Assets
Total assets¥23.7bnat 2022-05-31Cons.Assets
Total assets¥23.6bnat 2021-08-31Cons.Total assets (5-year summary)
Total liabilities¥16.5bnat 2022-08-31Cons.Liabilities
Total liabilities¥17.0bnat 2022-05-31Cons.Liabilities
Net assets / equity¥6.7bnat 2022-08-31Cons.Net assets
Net assets / equity¥6.7bnat 2022-05-31Cons.Net assets
Net assets / equity¥6.3bnat 2021-08-31Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2022-08-31Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥11.882022-06-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.992021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.832021-06-01 → 2021-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥8.992022-06-01 → 2022-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.292021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥5.182021-06-01 → 2021-08-31Cons.Diluted earnings per share (5-year summary)
Equity ratio27.6%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.9%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio25.2%at 2021-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2022-08-31¥204m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2022-08-31¥204m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2022-08-31¥21m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-08-31−¥75m
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2022-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2022-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2022-08-31−¥35m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2022-08-31¥169m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2022-08-31¥169m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2022-08-31¥20m
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2022-08-31¥10.4bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2022-08-31¥10.4bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2022-08-31¥398m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-08-31¥19m
—segment totalrevenue2022-06-01 → 2022-08-31¥12.7bn
—segment totalrevenue external2022-06-01 → 2022-08-31¥12.7bn
—segment totalsegment profit2022-06-01 → 2022-08-31¥402m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-08-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-08-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-08-31¥424m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-06-01 → 2021-08-31¥273m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-06-01 → 2021-08-31¥273m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-06-01 → 2021-08-31−¥8m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-08-31−¥73m
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2021-06-01 → 2021-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2021-06-01 → 2021-08-31¥2.0bn
jpcrp040300-q1r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2021-06-01 → 2021-08-31−¥14m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2021-06-01 → 2021-08-31¥163m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2021-06-01 → 2021-08-31¥163m
jpcrp040300-q1r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2021-06-01 → 2021-08-31¥21m
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue2021-06-01 → 2021-08-31¥10.5bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2021-06-01 → 2021-08-31¥10.5bn
jpcrp040300-q1r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2021-06-01 → 2021-08-31¥377m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue2021-06-01 → 2021-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentrevenue external2021-06-01 → 2021-08-31¥126m
jpcrp040300-q1r_E05379-000Medical Mallreportable segmentsegment profit2021-06-01 → 2021-08-31¥14m
—segment totalrevenue2021-06-01 → 2021-08-31¥12.8bn
—segment totalrevenue external2021-06-01 → 2021-08-31¥12.8bn
—segment totalsegment profit2021-06-01 → 2021-08-31¥399m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-08-31¥13.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-08-31¥13.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-08-31¥391m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 379
ItemContextValueUnit
Cost of salesPrior1YTDDuration11023000000JPY
Cost of salesCurrentYTDDuration10763000000JPY
Gross profitPrior1YTDDuration2039000000JPY
Gross profitCurrentYTDDuration2098000000JPY
Selling general and administrative expensesPrior1YTDDuration1721000000JPY
Selling general and administrative expensesCurrentYTDDuration1749000000JPY
Operating incomePrior1YTDDuration317000000JPY
Operating incomeCurrentYTDDuration348000000JPY
Interest income noiPrior1YTDDuration0JPY
Interest income noiCurrentYTDDuration0JPY
Dividends income noiPrior1YTDDuration1000000JPY
Dividends income noiCurrentYTDDuration0JPY
Rent income noiPrior1YTDDuration5000000JPY
Rent income noiCurrentYTDDuration3000000JPY
Insurance income noiPrior1YTDDuration18000000JPY
Insurance income noiCurrentYTDDuration1000000JPY
Other noiPrior1YTDDuration15000000JPY
Other noiCurrentYTDDuration9000000JPY
Non operating incomePrior1YTDDuration40000000JPY
Non operating incomeCurrentYTDDuration16000000JPY
Interest expenses noePrior1YTDDuration17000000JPY
Interest expenses noeCurrentYTDDuration14000000JPY
Commission fee noePrior1YTDDuration1000000JPY
Commission fee noeCurrentYTDDuration5000000JPY
Rent cost noePrior1YTDDuration2000000JPY
Rent cost noeCurrentYTDDuration2000000JPY
Other noePrior1YTDDuration1000000JPY
Other noeCurrentYTDDuration1000000JPY
Non operating expensesPrior1YTDDuration22000000JPY
Non operating expensesCurrentYTDDuration23000000JPY
Ordinary incomePrior1YTDDuration335000000JPY
Ordinary incomeCurrentYTDDuration341000000JPY
Subsidy eiPrior1YTDDuration－JPY
Subsidy eiCurrentYTDDuration5000000JPY
Extraordinary incomePrior1YTDDuration－JPY
Extraordinary incomeCurrentYTDDuration5000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration2000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration0JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration21000000JPY
Impairment loss elPrior1YTDDuration42000000JPY
Impairment loss elCurrentYTDDuration－JPY
Loss on reduction of noncurrent assets elPrior1YTDDuration－JPY
Loss on reduction of noncurrent assets elCurrentYTDDuration5000000JPY
Extraordinary lossPrior1YTDDuration42000000JPY
Extraordinary lossCurrentYTDDuration28000000JPY
Income before income taxesPrior1YTDDuration293000000JPY
Income before income taxesCurrentYTDDuration318000000JPY
Income taxesPrior1YTDDuration230000000JPY
Income taxesCurrentYTDDuration203000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2022-08-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-08-31pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-08-31pass
statement vs summary · revenueconsolidated 2021-06-01/2021-08-31pass
statement vs summary · revenueconsolidated 2022-06-01/2022-08-31pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-08-31pass